eResearch is an integrated platform providing end-to-end functionalities for all phases of a remote research study, including recruiting, screening, consenting, surveys, tele-medicine, tele-support, real-time payments, reporting, and analytics.

Yes, absolutely. We have taken extensive precautions to secure data, communications and continuously conduct extensive testing to validate and secure the platform. We’re using the latest encryption for data at rest as well as data in transit. 

Our Mobile App is supported on the following platforms:

• iOS 11.0 or later (iPhone, iPod touch, and/or iPad)
• Android 5.0 and later

To set up an eResearch account, start by downloading the eResearch mobile app on either the Apple App Store or the Google Play Store. Once you have downloaded the app, open it, and click the “Register Here” button. Fill out the form to receive an SMS message with your activation code to the phone number you provided. Once you receive your activation code, copy it, and go back to the eResearch app. Click the “Register Here” button again, then click the “Enter Activation Code” button. Enter, or paste, the activation code here and you will automatically be taken to your new eResearch account.

To pre-determine your eligibility for our studies, please go to your Volunteer Profile and complete the demographics, nicotine use, and health history sections to 100% and a member of our staff will contact you regarding next steps.

No! eResearch is a free-to-download mobile application, requiring no in-app purchases. In fact, all active enrolled study participants are compensated for their time. Compensation ranges vary depending on the study and the participants level of compliance with study assessments and visits.

Yes, to stay up to date regarding new on-site and remote studies available, we encourage all nicotine users to download eResearch and keep their profile updated. If there is a new study available, on-site or remote, you can learn more about it in the “Studies” tab in the app.

If you agree to take part in any of our research studies, information about your identity, health and your participation will be collected, recorded, and stored by study staff.

Rose Research Center, the study sponsor, the U.S. Food and Drug Administration (FDA), other health authorities, and the Institutional Review Board (IRB) may inspect your hard-copy and electronically stored study records which may include your name, address and other personal information that identifies you. If necessary, some of these records may be copied during these inspections.

The results of this research study may be presented at meetings or in publications. However, you will not be personally identified in any presentations or publications.

The informed consent process provides you with the information required to ensure you make an informed decision about participation in the clinical research study. This process will:

• Help you to understand the study
• Give you an opportunity to ask questions and to consider whether to participate
• Obtain your voluntary agreement to participate
• Continue to provide information as the clinical research study progresses

Before participating, we will take you through an Informed Consent Form (ICF) that outlines important information to consider before joining the study. The study staff will review this document with you and answer any questions you may have. This document provides details of the study, such as study expectations, duration, and what you will need to do. All known possible risks and potential benefits are also explained in the ICF. After you have read and discussed all the information about the study, you can decide whether or not to sign the consent form. This consent form is not a contract, and you are always free to leave the study at any time and for any reason, with no penalty to you. Additionally, during your participation, the study staff will let you know in a timely manner any information that may change your mind about participating.